RSK2 regulates drug resistance, cell motility, and invasion in many cancers including GBM (Sulzmaier and Ramos, 2013; Sulzmaier et al., 2016; Shi et al., 2018). The gene discussed is RPS6KA3; the disease is glioblastoma.